BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 5820389)

  • 1. [Study on long-active effect of antiepileptic agents].
    Kobayashi K; Takamizawa M; Kobayashi T; Otaka T; Fukuzawa H
    No To Shinkei; 1969 Jul; 21(7):735-42. PubMed ID: 5820389
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluctuations of plasma phenytoin levels on single dose and twice daily dose regimes.
    Vajda FJ; Merory J; Bladin PF
    Proc Aust Assoc Neurol; 1975; 12():61-4. PubMed ID: 1215397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paradoxical seizures in phenytoin toxicity.
    Chua HC; Venketasubramanian N; Tan CB; Tjia H
    Singapore Med J; 1999 Apr; 40(4):276-7. PubMed ID: 10487084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of acute seizures and status epilepticus with intravenous phenytoin.
    Leppik IE; Patrick BK; Cranford RE
    Adv Neurol; 1983; 34():447-51. PubMed ID: 6829350
    [No Abstract]   [Full Text] [Related]  

  • 5. [Monitoring of plasma diphenylhydantoin levels in epileptic patients].
    Lezama-Dávila CM; Olmos-García de Alba G; López-Anaya A; Valarezo-Crespo F
    Bol Med Hosp Infant Mex; 1983 May; 40(5):256-61. PubMed ID: 6871012
    [No Abstract]   [Full Text] [Related]  

  • 6. [Some experience in antiepileptic treatment drugs monitoring in clinic].
    Li J
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Jun; 21(3):145-8, 188-9. PubMed ID: 2906582
    [No Abstract]   [Full Text] [Related]  

  • 7. [Ethnic differences in serum phenytoin levels].
    Dam M; Hübbe P; Christiansen J
    Ugeskr Laeger; 1974 Aug; 136(35):1974-6. PubMed ID: 4848674
    [No Abstract]   [Full Text] [Related]  

  • 8. [Determination of serum diphenylhydantoin during antiepileptic therapy].
    Müller-Stüler M
    Nervenarzt; 1976 Apr; 47(4):244-7. PubMed ID: 1272481
    [No Abstract]   [Full Text] [Related]  

  • 9. [Decrease of folic acid and cognitive alterations in patients with epilepsy treated with phenytoin or carbamazepine, pilot study].
    Hernández R; Fernández Mde L; Miranda G; Suástegui R
    Rev Invest Clin; 2005; 57(4):522-31. PubMed ID: 16315636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diphenylhydantoin in the comprehensive treatment of epileptic attacks].
    Kolínová M; Kristof M; Maresová S
    Cesk Neurol Neurochir; 1982 Nov; 45(6):410-7. PubMed ID: 7151206
    [No Abstract]   [Full Text] [Related]  

  • 11. Diphenylhydantoin dosage.
    Eadie MJ; Tyrer JH; Hooper WD
    Proc Aust Assoc Neurol; 1973; 10(0):53-9. PubMed ID: 4792162
    [No Abstract]   [Full Text] [Related]  

  • 12. [Phenytoin serum concentration in epileptic patients: influence of therapeutic and physiological factors (author's transl)].
    May T; Stenzel E; Rambeck B
    Nervenarzt; 1982 May; 53(5):291-6. PubMed ID: 7099314
    [No Abstract]   [Full Text] [Related]  

  • 13. Prolonged use of phenytoin, carbamazepine or valproate monotherapy on plasma levels of folate and B(12): a comparison between epileptic patients with or without cardiovascular disorders.
    Otoom S; Bakhiet M; Khan A; Sequeira R
    Neuro Endocrinol Lett; 2006; 27(1-2):85-8. PubMed ID: 16648782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic drug monitoring of antiepileptic drugs.
    Shakya G; Malla S; Shakya KN; Shrestha R
    JNMA J Nepal Med Assoc; 2008; 47(171):94-7. PubMed ID: 19079370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti epileptic therapy with diphenylhydantoin with serum controls in childhood. Clinical experiences].
    Nolte R; Brügmann G; Besch W
    Bibl Psychiatr; 1975; (151):43-8. PubMed ID: 1156347
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug estimation in the treatment of epilepsy.
    Richens A
    Proc R Soc Med; 1974 Dec; 67(12 Pt 1):1227-9. PubMed ID: 4449865
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical significance of blood levels of diphenylhydantoin orally administered to epileptic patients].
    Ma ZZ
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Jun; 18(3):136-8. PubMed ID: 4053817
    [No Abstract]   [Full Text] [Related]  

  • 18. Kinetics of intravenous phenytoin in children.
    Koren G; Brand N; Halkin H; Dany S; Shahar E; Barzilay Z
    Pediatr Pharmacol (New York); 1984; 4(1):31-8. PubMed ID: 6739185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic drug monitoring and clinical outcomes in epileptic Egyptian patients: a gene polymorphism perspective study.
    Ebid AH; Ahmed MM; Mohammed SA
    Ther Drug Monit; 2007 Jun; 29(3):305-12. PubMed ID: 17529887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Personality and sex behavior among epileptics during long term treatment with DPH].
    Schmitz I; Janzik HH; Mayer K
    Bibl Psychiatr; 1975; (151):176-81. PubMed ID: 1156344
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.